IT1271031B - Composizioni farmaceutiche miorilassanti - Google Patents

Composizioni farmaceutiche miorilassanti

Info

Publication number
IT1271031B
IT1271031B ITMI942166A ITMI942166A IT1271031B IT 1271031 B IT1271031 B IT 1271031B IT MI942166 A ITMI942166 A IT MI942166A IT MI942166 A ITMI942166 A IT MI942166A IT 1271031 B IT1271031 B IT 1271031B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
myo
relaxing
stabilizers
substances
Prior art date
Application number
ITMI942166A
Other languages
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1271031(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to ITMI942166A priority Critical patent/IT1271031B/it
Publication of ITMI942166A0 publication Critical patent/ITMI942166A0/it
Priority to DK95115576.1T priority patent/DK0707853T3/da
Priority to EP95115576A priority patent/EP0707853B1/en
Priority to DE0707853T priority patent/DE707853T1/de
Priority to DE69500490T priority patent/DE69500490T2/de
Priority to AT95115576T priority patent/ATE156016T1/de
Priority to ES95115576T priority patent/ES2088379T3/es
Priority to CA002160938A priority patent/CA2160938C/en
Priority to US08/586,088 priority patent/US5767112A/en
Publication of ITMI942166A1 publication Critical patent/ITMI942166A1/it
Priority to GR960300039T priority patent/GR960300039T1/el
Publication of IT1271031B publication Critical patent/IT1271031B/it
Application granted granted Critical
Priority to GR970402416T priority patent/GR3024761T3/el
Priority to HK98100704A priority patent/HK1001719A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Abstract

Vengono descritte composizioni farmaceutiche adatte alla somministrazione parenterale in grado di procurare rilassamento muscolare contenenti vecuronio bromuro e sostanze di natura zwitterionica come stabilizzanti.
ITMI942166A 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti IT1271031B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti
EP95115576A EP0707853B1 (en) 1994-10-21 1995-10-02 Muscle relaxant pharmaceutical compositions
AT95115576T ATE156016T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende arzneizubereitungen
ES95115576T ES2088379T3 (es) 1994-10-21 1995-10-02 Composiciones farmaceuticas relajantes musculares.
DE0707853T DE707853T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen
DE69500490T DE69500490T2 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen
DK95115576.1T DK0707853T3 (da) 1994-10-21 1995-10-02 Muselrelakserende farmaceutiske præparater
CA002160938A CA2160938C (en) 1994-10-21 1995-10-19 Muscle relaxant pharmaceutical compositions
US08/586,088 US5767112A (en) 1994-10-21 1996-01-16 Muscle relaxant pharmaceutical compositions
GR960300039T GR960300039T1 (en) 1994-10-21 1996-08-31 Muscle relaxant pharmaceutical compositions
GR970402416T GR3024761T3 (en) 1994-10-21 1997-09-17 Muscle relaxant pharmaceutical compositions
HK98100704A HK1001719A1 (en) 1994-10-21 1998-01-27 Muscle relaxant pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (3)

Publication Number Publication Date
ITMI942166A0 ITMI942166A0 (it) 1994-10-21
ITMI942166A1 ITMI942166A1 (it) 1996-04-21
IT1271031B true IT1271031B (it) 1997-05-26

Family

ID=11369756

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Country Status (9)

Country Link
EP (1) EP0707853B1 (it)
AT (1) ATE156016T1 (it)
CA (1) CA2160938C (it)
DE (2) DE69500490T2 (it)
DK (1) DK0707853T3 (it)
ES (1) ES2088379T3 (it)
GR (2) GR960300039T1 (it)
HK (1) HK1001719A1 (it)
IT (1) IT1271031B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
DE60034366T2 (de) * 1999-12-22 2007-12-20 Glaxo Group Ltd., Greenford Verfahren zur herstellung pharmazeutischer formulierungen
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331930T2 (de) * 1992-02-18 2003-01-09 Pharmos Corp Trockene zusammensetzungen zur herstellung von emulsionen im submikron-bereich
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
EP0707853A1 (en) 1996-04-24
DE69500490D1 (de) 1997-09-04
ES2088379T1 (es) 1996-08-16
ATE156016T1 (de) 1997-08-15
EP0707853B1 (en) 1997-07-30
HK1001719A1 (en) 1998-07-03
DE707853T1 (de) 1996-12-12
ES2088379T3 (es) 1997-10-16
ITMI942166A0 (it) 1994-10-21
DE69500490T2 (de) 1997-12-04
CA2160938A1 (en) 1996-04-22
DK0707853T3 (da) 1998-03-02
CA2160938C (en) 2008-07-15
GR960300039T1 (en) 1996-08-31
GR3024761T3 (en) 1997-12-31
ITMI942166A1 (it) 1996-04-21

Similar Documents

Publication Publication Date Title
NO981436D0 (no) Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav
MA23895A1 (fr) Amides therapeutiques et compositions les contenant
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
NO992803L (no) Substansblandinger inneholdende stabiliseringsmidler og sammensetninger inneholdende vinylgrupper
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
BR9609951A (pt) Novas composições farmacêuticas e seu uso
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO20002786D0 (no) Adamantanderivater
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
NO20001488L (no) ForhÕndsfylte ampuller og tilvirkning derav
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
IT1237410B (it) Compressa di cloridrato di ranitidina e procedimento per produrla
BR9812182A (pt) Cloreto de n,n-bis(fenilcarbamoilmetil) dimetilamÈnio e seus derivados no tratamento da dor
IT1271031B (it) Composizioni farmaceutiche miorilassanti
ATE243196T1 (de) Piperidine und pyrrolidine
ATE186541T1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE69428456T2 (de) Silikon-modifizierte phospholipid-zusammensetzungen
DK0508334T3 (da) Aminophenolderivater og farmaceutiske præparater indeholdende disse
PT1288203E (pt) Nitronas ciclicas e composicoes farmaceuticas que as contem
NO975365L (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
IT1285544B1 (it) Composizione a base di uova di quaglia e suo impiego farmaceutico oppure cosmetico
FR2774990B1 (fr) Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029